Edstein M D, Veenendaal J R, Scott H V, Rieckmann K H
Army Malaria Research Unit, Milpo, Ingleburn, Australia.
Chemotherapy. 1988;34(5):385-92. doi: 10.1159/000238597.
The pharmacokinetics of proguanil and its active metabolite, cycloguanil, were determined at steady-state in 6 healthy male volunteers after daily administration of 2 Paludrine tablets (200 mg proguanil hydrochloride). A maximum plasma proguanil concentration of 130.3 +/- 16.0 ng/ml (mean +/- SD) was reached at 3.8 +/- 1.3 h while a maximum cycloguanil concentration of 52.0 +/- 15.2 ng/ml was obtained at 5.3 +/- 1.0 h after dosing. The elimination half-lives of proguanil and cycloguanil were 14.5 +/- 3.0 h and 11.7 +/- 3.1 h, respectively. The plasma clearance of proguanil was 1.43 +/- 0.33 l/h/kg and the apparent volume of distribution was 30.7 +/- 12.3 l/kg. Renal clearance of proguanil (0.33 +/- 0.19 l/h/kg) was about 23% of the plasma clearance and 35.6 +/- 9.6% of the oral dose was recovered as proguanil and cycloguanil.
在6名健康男性志愿者每日服用2片百乐君片剂(200毫克盐酸氯胍)后,在稳态下测定了氯胍及其活性代谢产物环氯胍的药代动力学。给药后3.8±1.3小时达到最大血浆氯胍浓度130.3±16.0纳克/毫升(平均值±标准差),而环氯胍最大浓度52.0±15.2纳克/毫升在给药后5.3±1.0小时获得。氯胍和环氯胍的消除半衰期分别为14.5±3.0小时和11.7±3.1小时。氯胍的血浆清除率为1.43±0.33升/小时/千克,表观分布容积为30.7±12.3升/千克。氯胍的肾清除率(0.33±0.19升/小时/千克)约为血浆清除率的23%,35.6±9.6%的口服剂量以氯胍和环氯胍形式回收。